Michael Method, MD, MPH, MBA
ImmunoGen, Inc.
1
0
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Ursula Matulonis, MD
Dana-Farber Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Robert Coleman, MD
The US Oncology Network
Shared therapeutic areas:
Worked with same sponsors:
Paul Sabbatini, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Amit Oza, M.D.
Princess Margaret Cancer Centre
Shared therapeutic areas:
Scott Holden, M.D.
Genentech, Inc.
Shared therapeutic areas:
David Avigan, MD
Beth Israel Deaconess Medical Center
Shared therapeutic areas:
Ingrid Mayer, MD
Vanderbilt-Ingram Cancer Center
Shared therapeutic areas:
Peter Eisenberg, MD
Marin Cancer Care
Shared therapeutic areas:
Robert Kreitman, MD
National Cancer Institute (NCI)
Shared therapeutic areas:
Giuseppe Del Priore, MD
Indiana University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
All 1 trials loaded